India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires

India has a huge generic drug market. They make all kinds of meds for low prices. Years ago there was a antivral drug for Hepatitis called Harvoni it was selling for $90.000 they were selling it for $100. Canada can produce ozempic generics but so far they're not been approved. You wonder whats holding them back? Canadian markets will be flooded with people on ozempic to lose weight.

India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest overweight population.

Natco Pharma Ltd. plans to make an injection for semaglutide — the active ingredient in both Ozempic and Wegovy — at one of the lowest starting prices of 1,290 rupees ($14) a month. Its pen device is expected to launch by April and cost about 4,500 rupees a month, it said in a filing.

By comparison, Novo’s Wegovy pen starts at about 10,480 rupees in India and about $199 in the U.S. under the self-pay model. Monthly prices for semaglutide products at others like Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd. and Glenmark Pharmaceuticals Ltd. range from about 1,300 rupees to 8,000 rupees.

While Canada was the first to lose patent protection for semaglutide in January, the Canadian health regulator hasn’t approved any generics so far, effectively making India the first major market to see a flood of copycat versions. The ensuing price war will be closely watched as the Danish drugmaker faces patent expiries in key markets including China, Brazil and Turkey.

Bloomberg News parsed company filings and earnings call transcripts to identify at least 12 large drugmakers that have plans to sell generic semaglutide soon after patent expiry. But the true scale of competition will be much higher.

About 42 drug manufacturers, including smaller ones, are expected to launch products under more than 50 brand names this year, said Sheetal Sapale, a researcher at market data firm Pharmarack.

blacksnacks said:

The price decrease is great news for my aunt. She's been taking them for the past few months and already down 20 pounds, but she has a butterface. She was bragging to my mom about going out shopping to buy new panties and pants saying guys will be checking her ass out each time she bends over. I asked her if she has an Amazon account because paperbags will be cheaper to buy from them. I think she blocked me on FB now, family drama.

Click to expand...

Some people do very well on it, but you have to stay on it for life otherwise you gain your weight back. I know a guy, he takes the maximum dosage and he's not doing well, they may transfer him to Mounjaro which is a little bit stronger.

A new Glp1 pill is out
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions


Weight-loss drugs crush food demand as farmers face dumping mountains of potatoes

Potato farmers say weight-loss drug use is gutting supermarket demand

The rapid rise of weight-loss injections is reshaping the quantity of food people eat — leaving farmers in some areas with a growing surplus of unsold potatoes.

The trend toward healthier eating habits, combined with the widespread use of drugs like Ozempic and Mounjaro, are cutting demand for traditional staples and weighing on grocery sales, news agency SWNS reported.

Farmers across the United Kingdom, for example, say they're facing the prospect of discarding thousands of tons of stored potatoes as their sales continue to fall.

Farm owner Andy Goodacre said he's been left with a surplus he cannot sell after demand from supermarkets declined in recent years, he told the outlet.

Goodacre currently has about 1.3 million pounds of his potatoes at risk of being dumped — stock valued at roughly $158,000.

"I've never known a season like it," Goodacre said. "It doesn't seem as though people want to eat like they used to."

The veteran farmer, who has supplied the industry for 40 years, said shoppers are increasingly choosing lentil-based alternatives over potato chips and french fries.

The appetite-suppressing effects of the drugs are directly affecting how much people eat and how often they visit restaurants, the news outlet said.

Goodacre said he knows many people in his local community who are taking the injections, and said the drop in demand for heavy meals is becoming difficult to ignore.

Andrew Crook, president of the National Federation of Fish Friers, told SWNS the trend is also affecting businesses as customers opt for smaller portions.

He said many regular customers have lost a significant amount of weight using the so-called "fat jabs." They now choose to share a single order of fries instead of buying their own, he said.

"There's definitely factors where people are going to use these jabs, lose weight and then eat less," Crook said.

He warned that if farmers cannot turn a profit on potatoes this year, the 2027 haul could fall short as growers shift to more profitable crops.

Andrew Crook, president of the National Federation of Fish Friers, told SWNS the trend is also affecting businesses as customers opt for smaller portions.

He said many regular customers have lost a significant amount of weight using the so-called "fat jabs." They now choose to share a single order of fries instead of buying their own, he said.

"There's definitely factors where people are going to use these jabs, lose weight and then eat less," Crook said.

He warned that if farmers cannot turn a profit on potatoes this year, the 2027 haul could fall short as growers shift to more profitable crops.

GioMo said:

I feel like lowering obesity rates globally, supersedes potato farming but that just might be me.

Click to expand...

Of course, let them plant a healthy crop instead.